Analysis of mitochondrial DNA mutations in Pakistani population diagnosed with cardiovascular diseases

F Ali1, S Ali2, S Mohamed2

  • 1Dalian Medical University, Department of Cell Biology, Dalian, Liaoning, China.

Insights

This study found no mutations in mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) in Pakistani cardiovascular disease (CVD) patients. Further research on larger populations and other mitochondrial genes is recommended for early CVD genetic screening.

Area of Science:

  • Genetics
  • Cardiology
  • Mitochondrial Biology

Background:

  • Cardiovascular disease (CVD) encompasses various heart and blood vessel disorders.
  • Mitochondrial DNA mutations are increasingly implicated in complex diseases.
  • The role of specific mitochondrial genes in CVD pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the association between mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) and cardiovascular disease (CVD).
  • To screen for mutations in MT-TL1 and MT-TL2 genes in a cohort of CVD patients from Peshawar, Pakistan.

Main Methods:

  • DNA was extracted from 27 saliva samples of CVD patients.
  • Mitochondrial Leucine Transfer RNA genes (MT-TL1 and MT-TL2) were amplified via polymerase chain reaction (PCR).
  • PCR products underwent purification, sequencing, and alignment against the revised Cambridge Reference Sequence (rCRS).

Main Results:

  • Sequencing and analysis revealed no alterations in the MT-TL1 and MT-TL2 genes within the studied patient samples.
  • The investigated mitochondrial Leucine Transfer RNA genes did not show mutations in this cohort.

Conclusions:

  • The study suggests that MT-TL1 and MT-TL2 genes may not be primary drivers of CVD in the studied Pakistani population.
  • Larger population screening for mutations in mitochondrial-encoded Leucine Transfer RNA genes is recommended for Pakistani cardiac patients.
  • Investigating other mitochondrial genes is advised for identifying potential genetic markers for early CVD detection in Pakistan.